Brimonidine Tartrate RC03552
1 Inquiries
70359-46-5
Pharmaceutical Grade
99%
Royalchem
25kg/drum
2030-01-01
Pharmaceutical intermediates
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceUK 14,304 is a full α2-adrenergic receptor (α2-AR) agonist.Target: α2-adrenergic Receptor[3H]UK 14,034 is a full agonist at alpha 2-adrenergic receptors. [3H]UK 14,304 labels at least 2 specific binding sites in human brain that both have the characteristics of an alpha 2-adrenergic binding site. GTP decreases agonist binding at both of these sites, but with different potencies at each site [1-3].
Brimonidine Tartrate is the tartrate salt form of brimonidine, an imidazole derivative and a selective alpha-2 adrenergic receptor agonist. Upon ocular administration, brimonidine tartrate acts on the blood vessels causing them to constrict which leads to a decrease in the production of aqueous humor. Brimonidine tartrate also enhances the outflow of aqueous humor. This drug is used in the treatment of glaucoma to reduce intraocular pressure.|A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.Basic Info-
Product Name:
Brimonidine tartrate
Other Name:6-Quinoxalinamine,5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-,(2R,3R)-2,3-dihydroxybutanedioate (1:1);6-Quinoxalinamine,5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-,[R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1);Brimonidine tartrate;AGN 190342LF;Brominide tartrate;Alphagan;Alphagan P;Brimonidine Purite;Mirvaso;(5-Bromo-quinoxalin-6-yl)-(4,5-dihydro-1H-imidazol-2-yl)-amine L-tartrate;109826-56-4;79570-19-7
CAS No.:70359-46-5
Molecular Formula:C11H10BrN5.C4H6O6
InChIKeys:InChIKey=QZHBYNSSDLTCRG-LREBCSMRSA-N
Molecular Weight:442.22
Exact Mass:441.028381
EC Number:1308068-626-2
UNII:4S9CL2DY2H
NCI Thesaurus Code:C47419
ATC Code:S01EC54|D11AX21
HScode:2933990090
Categories:
Characteristics-
PSA:
177
XLogP3:-0.52180
Appearance:Off-white crystalline solid
Melting Point:207.5 °C
Boiling Point:432.6°C at 760 mmHg
Flash Point:215.4ºC
Storage Conditions:-20°C Freezer
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 3, Oral
Specific target organ toxicity â repeated exposure, Category 2
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H301 Toxic if swallowed
H373 May cause damage to organs through prolonged or repeated exposure
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P260 Do not breathe dust/fume/gas/mist/vapours/spray.
Response P301+P316 IF SWALLOWED: Get emergency medical help immediately.
P321 Specific treatment (see ... on this label).
P330 Rinse mouth.
P319 Get medical help if you feel unwell.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Pharmaceutical intermediates
-
Location:
Room 336, Building 7, No. 177 Xingqiao North Road, Xingqiao Street, Linping District, Hangzhou
-
Payment Terms:
TT against copy of documents,D/P,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
14
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
Less than 5
-
Year of Establishment:
2025
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted 
United States
brimonidine tartrate
20 G Feb 7, 2025 Post an enquiry for this product